The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Pharmaids Pharmaceuticals Ltd

Pharmaids Pharmaceuticals Ltd

BSE 524572 · NSE PHARMAID · ISIN INE117D01018 · Group X · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹32.29

+2.90%

BSE close, 28 August 2026

Market cap

₹113.88 cr

3.5 cr shares · Micro cap

Free float

₹56.46 cr

as published

P/E · P/B

-28.8× · 1.66×

EPS ₹-1.12 · BV ₹19.45

FY25-26 rev / PAT

10.60 / -10.44

₹ cr, as filed

Filings, window

11

2 selected · 18%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹25.60 52-WK HIGH ₹66.00 ₹32.29 17% of range
Against 52-week high-51.1%
Against 52-week low+26.1%
Day change+2.90%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹-1.12
Price / earnings-28.83×
Price / book1.66×
Book value — derived, price ÷ P/B₹19.45
Return on equity-5.76%
Operating margin—
Net margin—

Consistency check

P/B ÷ P/E, which must equal ROE
-5.76%
ROE as published
-5.76%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q — 2.14 0.61 — —
Mar-26 · Q 2.69 -1.31 -0.37 -38.60% -48.79%
FY25-26 10.60 -10.44 -2.95 -98.43% -98.43%

Quarter on quarter

Net profit, quarter on quarter
+263.4%

Disclosure profile 11 filings in the window

0 median 17.0 p75 · 25 sector max 52 11 22th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Results1
Selected sub-total2
Procedural
AGM / EGM3
Newspaper Publication2
Annual Report1
Board Meeting1
General1
Trading Window1
Procedural sub-total9
Total11

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group X, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

11 filings · 2 selected · busiest 2026-08-12 and 2026-08-18

Filing rhythm · the twelve most recent

2026-08-062026-09-25

SelectedProcedural

Filings

11 in the window · 4 earlier on record

  1. 25 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation w.r.t Closure of Trading Window

    Insider Trading / SAST / Closure of Trading Window View filing →

  2. 16 September 2026 ·

    General

    Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

    Pursuant to the Regulation 30(3) & 30(4) read with Para B of Part A of Schedule III of SEBI (Listing Obligations and Disclosure requirements) Regulations 2015, we hereby inform that the ....

    Company Update / General View filing →

  3. 15 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Voting Results along with the Scrutinizer's Report of the 37th AGM of the Company held on 11th September 2026 through VC/ OAVM.

    AGM/EGM / AGM View filing →

  4. 11 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Outcome of the 37th Annual General Meeting of the Company held on September 11, 2026 i.e., today at 12 noon through VC/OAVM.

    AGM/EGM / AGM View filing →

  5. 19 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Enclosed copies of Newspaper Advertisement published on August 19, 2026 intimating the Notice of 37th Annual General Meeting of the Company

    Company Update / Newspaper Publication View filing →

  6. 18 August 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Annual Report

    Others / Reg. 34 (1) Annual Report View filing →

  7. 18 August 2026 ·

    AGM / EGM

    Notice Of 37Th Annual General Meeting And Annual Report

    Notice of 37th AGM and Annual Report

    AGM/EGM / AGM View filing →

  8. 14 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper publication of unaudited financial results (standalone & consolidated) for the quarter ended June 30, 2026

    Company Update / Newspaper Publication View filing →

  9. 12 August 2026 ·

    Results

    Submission Of Unaudited Financial Results For The Quarter Ended June 30, 2026

    Submission of unaudited financial results

    Result / Financial Results View filing →

  10. 12 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Board Meeting Outcome For August 12, 2026

    Outcome of the Board meeting held today i.e. August 12, 2026

    Board Meeting / Outcome of Board Meeting View filing →

  11. 6 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended 30Th June 2026.

    Pharmaids Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....

    Board Meeting / Board Meeting View filing →

RSS feed for Pharmaids Pharmaceuticals Ltd · the 50 most recent filings